EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine

Joelle Reich, Paul M Riegelhaupt, Stephen J Tucker, Conor McClenaghan

Molecular Pharmacology · 2026-10 · 108 (10) · 100155

DOI: 10.1016/j.molpha.2026.100155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2026-10. Verfasst von Joelle Reich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey, Piscataway, New Jers…. Hauptthemen laut MEDLINE: Carvedilol, Potassium Channels, Tandem Pore Domain, Fluphenazine, Potassium Channel Blockers. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarvedilolPotassium Channels, Tandem Pore DomainFluphenazinePotassium Channel BlockersHumansAnimalsBinding SitesHEK293 CellsMolecular Docking SimulationProtein Conformation

Stichwörter der Autor:innen

CarvedilolFluoxetineFluphenazineNorfluoxetineTREK-1TREK-2

Substanzen

CarvedilolPotassium Channels, Tandem Pore DomainFluphenazinePotassium Channel Blockerspotassium channel protein TREK-1

Autor:innen und Institutionen

  • Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey, Piscataway, New Jersey; Department of Pharmacology, Robert Wood Johnson Medical School, Ru…
  • Department of Anesthesiology, Weill Cornell Medical College, New York, New York.
  • Clarendon Laboratory, Department of Physics, University of Oxford, Oxford, United Kingdom; Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, United Kingdom.

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Reich, J., Riegelhaupt, P. M., Tucker, S. J., & McClenaghan, C. (2026). A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine. Molecular Pharmacology, 108(10), 100155. https://doi.org/10.1016/j.molpha.2026.100155

Vancouver

Reich J, Riegelhaupt PM, Tucker SJ, McClenaghan C. A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine. Molecular Pharmacology. 2026;108(10):100155. doi:10.1016/j.molpha.2026.100155

BibTeX
@article{Reich2026,
  author = {Reich, Joelle and Riegelhaupt, Paul M and Tucker, Stephen J and McClenaghan, Conor},
  title = {A conserved conformation-dependent mechanism for the TREK two-pore domain potassium channel inhibitors carvedilol and fluphenazine},
  journal = {Molecular Pharmacology},
  year = {2026},
  volume = {108},
  number = {10},
  pages = {100155},
  doi = {10.1016/j.molpha.2026.100155}
}
Kostenlos starten →